DEBT AND EQUITIES
BioSante Pharmaceuticals, Baudette, received a letter from Nasdaq informing BioSante that, since the merger with ANIP Acquisition Co. earlier this week, BioSante was required to meet the initial listing criteria for the Nasdaq Global Market. BioSante did not meet the minimum $4 bid price requirement for initial listings and Nasdaq decided to delist BioSante's securities. BioSante intends to appeal the decision.
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More From Star Tribune
More From Business
Business
These apps allow workers to get paid between paychecks. Experts say there are steep costs
When Anna Branch, 37, had her hours at work reduced in 2019, she suddenly noticed ads for an app called EarnIn.
Business
Net neutrality restored as FCC votes to regulate internet providers
The FCC on Thursday restored ''net neutrality'' rules that prevent broadband internet providers such as Comcast and AT&T from favoring some sites and apps over others.
Business
Google parent reports another quarter of robust growth, rolls out first-ever quarterly dividend
Google's corporate parent Alphabet Inc. on Thursday released a quarterly report showing it's still reaping double-digit revenue gains from its digital advertising empire while sowing potentially lucrative new ground in artificial intelligence.
Business
Biden celebrates computer chip factories, pitching voters on American 'comeback'
President Joe Biden on Thursday sought to sell voters on an American ''comeback story'' as he highlighted longterm investments in the economy in upstate New York to celebrate Micron Technology's plans to build a campus of computer chip factories made possible in part with government support.
Business
Stock market today: Wall Street falls on double dose of disappointing economic data, as Meta sinks
Worries about a potentially toxic cocktail combining stubbornly high inflation with a flagging economy dragged U.S. stocks lower on Thursday. A sharp drop for Facebook's parent company, one of Wall Street's most influential stocks, also hurt the market.
